|
Instructions to the Authors
Revised November, 2008
|
About the Journal: |
 |
| |
The International Journal for Ayurveda Research, a publication of
Dept. of AYUSH, Govt. of India, is a quarterly peer-reviewed international
journal. The journal’s full text is available online at
www.ijaronline.com . The journal allows
free access (Open Access) to its contents and permits authors to self-archive
final accepted version of the articles on any OAI-compliant institutional /
subject-based repository. The journal does not charge for submission, processing
or publication of manuscripts and even for color reproduction of photographs.
This is the first journal from India that can present to the world the wealth of
science generated in Ayurveda in the medical schools and research organizations
in the country.
|
Scope of the journal |
|
| |
The journal will be to:
- Provide a common platform for publication of research in
Ayurveda
- Promote research culture among students of Ayurveda
- Update research in Traditional medicine in the country
and abroad
- Describe various centers and academic institutes
conducting research in Traditional Medicine in the world to
enhance interaction.
- Have a special section for research students giving them
a direction for their future goals.
|
The Editorial Process |
|
A manuscript will be reviewed for possible publication with
the understanding that it is being submitted to IJAR alone at
that point in time and has not been published anywhere,
simultaneously submitted, or already accepted for publication
elsewhere. The journal expects that authors would authorize one
of them to correspond with the Journal for all matters related
to the manuscript. All manuscripts received are duly
acknowledged. On submission, editors review all submitted
manuscripts initially for suitability for formal review.
Manuscripts with insufficient originality, serious scientific or
technical flaws, or lack of a significant message are rejected
before proceeding for formal peer-review. Manuscripts that are
unlikely to be of interest to the IJAR readers are also liable
to be rejected at this stage itself.
Manuscripts that are found suitable for publication in IJAR
are sent to two or more expert reviewers. During submission, the
contributor is requested to provide names of two or three
qualified reviewers who have had experience in the subject of
the submitted manuscript, but this is not mandatory. The
reviewers should not be affiliated with the same institutes as
the contributor/s. However, the selection of these reviewers is
at the sole discretion of the editor. The journal follows a
double-blind review process, wherein the reviewers and authors
are unaware of each other’s identity. Every manuscript is also
assigned to a member of the editorial team, who based on the
comments from the reviewers takes a final decision on the
manuscript. The comments and suggestions (acceptance/ rejection/
amendments in manuscript) received from reviewers are conveyed
to the corresponding author. If required, the author is
requested to provide a point by point response to reviewers’
comments and submit a revised version of the manuscript. This
process is repeated till reviewers and editors are satisfied
with the manuscript.
Manuscripts accepted for publication are copy edited for
grammar, punctuation, print style, and format. Page proofs are
sent to the corresponding author. The corresponding author is
expected to return the corrected proofs within three days. It
may not be possible to incorporate corrections received after
that period. The whole process of submission of the manuscript
to final decision and sending and receiving proofs is completed
online. To achieve faster and greater dissemination of knowledge
and information, the journal publishes articles online as ‘Ahead
of Print’ immediately on acceptance.
|
Authorship Criteria |
|
Authorship credit should be based only on substantial
contributions to each of the three components mentioned below:
- Concept and design of study or acquisition of data or
analysis and interpretation of data;
- Drafting the article or revising it critically for
important intellectual content; and
- Final approval of the version to be published.
Participation solely in the acquisition of funding or the
collection of data does not justify authorship. General
supervision of the research group is not sufficient for
authorship. Each contributor should have participated
sufficiently in the work to take public responsibility for
appropriate portions of the content of the manuscript. The order
of naming the contributors should be based on the relative
contribution of the contributor towards the study and writing
the manuscript. Once submitted the order cannot be changed
without written consent of all the contributors. The journal
prescribes a maximum number of authors for manuscripts depending
upon the type of manuscript, its scope and number of
institutions involved (vide infra). The authors should provide a
justification, if the number of authors exceeds these limits.
|
Contribution Details |
|
Contributors should provide a description of contributions made by each of them
towards the manuscript. Description should be divided in following categories,
as applicable: concept, design, definition of intellectual content, literature
search, clinical studies, experimental studies, data acquisition, data analysis,
statistical analysis, manuscript preparation, manuscript editing and manuscript
review. Authors' contributions will be printed along with the article. One or
more author should take responsibility for the integrity of the work as a whole
from inception to published article and should be designated as 'guarantor'.
|
Conflicts of Interest/ Competing Interests |
|
All authors of must disclose any and all conflicts of interest they may have
with publication of the manuscript or an institution or product that is
mentioned in the manuscript and/or is important to the outcome of the study
presented. Authors should also disclose conflict of interest with products that
compete with those mentioned in their manuscript.
|
Submission of Manuscripts: |
|
All manuscripts
must be submitted on-line through the website
www.journalonweb.com/ijar. First time users will have to register at this
site. Registration is free but mandatory. Registered authors can keep track of
their articles after logging into the site using their user name and password.
Authors do not have to pay for submission, processing or publication of
articles. If you experience any problems, please contact the editorial office by
e-mail at editor [AT] ijaronline [DOT] com editor.ijar [AT]gmail [DOT] com .
The submitted
manuscripts that are not as per the “Instructions to Authors” would be returned
to the authors for technical correction, before they undergo editorial/
peer-review. Generally, the manuscript should be submitted in the form of two
separate files:
- Title Page/First Page File/covering letter:
This file should provide
- The type of manuscript (original article, case report, review article,
Ethics Forum, Education Forum, Letter to editor, Images, etc.) title of the
manuscript, running title, names of all authors/ contributors (with their
highest academic degrees, designation and affiliations) and name(s) of
department(s) and/ or institution(s) to which the work should be credited, . All
information which can reveal your identity should be here. Use text/rtf/doc
files. Do not zip the files.
- The total number of pages, total number of photographs and word counts
separately for abstract and for the text (excluding the references, tables and
abstract), word counts for introduction + discussion in case of an original
article;
- Source(s) of support in the form of grants, equipment, drugs, or all of
these;
- Acknowledgement, if any. One or more statements should specify 1)
contributions that need acknowledging but do not justify authorship, such as
general support by a departmental chair; 2) acknowledgments of technical help;
and 3) acknowledgments of financial and material support, which should specify
the nature of the support. This should be included in the title page of the
manuscript and not in the main article file.
- If the manuscript was presented as part at a meeting, the organization,
place, and exact date on which it was read. A full statement to the editor about
all submissions and previous reports that might be regarded as redundant
publication of the same or very similar work. Any such work should be referred
to specifically, and referenced in the new paper. Copies of such material should
be included with the submitted paper, to help the editor decide how to handle
the matter.
- Registration number in case of a clinical trial and where it is registered
(name of the registry and its URL)
- Conflicts of Interest of each author/ contributor. A statement of financial
or other relationships that might lead to a conflict of interest, if that
information is not included in the manuscript itself or in an authors' form
- Criteria for inclusion in the authors’/ contributors’ list
- A statement that the manuscript has been read and approved by all the
authors, that the requirements for authorship as stated earlier in this document
have been met, and that each author believes that the manuscript represents
honest work, if that information is not provided in another form (see below);
and
- The name, address, e-mail, and telephone number of the corresponding author,
who is responsible for communicating with the other authors about revisions and
final approval of the proofs, if that information is not included on the
manuscript itself.
- Blinded Article file: The manuscript must not contain any mention of the
authors' names or initials or the institution at which the study was done or
acknowledgements. Page headers/running title can include the title but not the
authors' names. Manuscripts not in compliance with The Journal's blinding policy
will be returned to the corresponding author. The main text of the article,
beginning from Abstract till References (including tables) should be in this
file. Use rtf/doc files. Do not zip the files. Limit the file size to 400 kb. Do
not incorporate images in the file. If file size is large, graphs can be
submitted as images separately without incorporating them in the article file to
reduce the size of the file. The pages should be numbered consecutively,
beginning with the first page of the blinded article file.
- Images: Submit good quality color images. Each image should be less than
1024 kb (1 MB) in size. Size of the image can be reduced by decreasing the
actual height and width of the images (keep up to 1240 x 800 pixels or 5-6
inches). Images can be submitted as jpeg files. Do not zip the files. Legends
for the figures/images should be included at the end of the article file.
- The contributors' / copyright transfer form (template provided below) has to
be submitted in original with the signatures of all the contributors within two
weeks of submission via courier, fax or email (copyright AT medknow DOT com) as
a scanned image. Print ready hard copies of the images (one set) or digital
images should be sent to the journal office at the time of submitting revised
manuscript. High resolution images (up to 5 MB each) can be sent by email on
images AT medknow DOT com).
The hard copies of the Contributors’ form / copyright transfer form may be sent
to the following addresses or submitted online from the authors’ area on
www.journalonweb.com/ijar.
International Journal of Ayurveda Research
Dept of Clinical Pharmacology
1st Floor, MS Building
GS Medical College and KEM Hospital,
Parel, Mumbai- 400012, India
|
Preparation of Manuscripts |
|
Manuscripts must be prepared in accordance with "Uniform
requirements for Manuscripts submitted to Biomedical Journals"
developed by the International Committee of Medical Journal
Editors (October 2006). The uniform requirements and specific
requirement of IJAR are summarized below. Before submitting a
manuscript, contributors are requested to check for the latest
instructions available. Instructions are also available from the
website of the journal (http://www.ijaronline.org) and from the
manuscript submission site (http://www.journalonweb.com/ijar).
IJAR accepts manuscripts written in UK English.
|
Copies of any permission(s) |
|
It is the responsibility of authors/ contributors to obtain
permissions for reproducing any copyrighted material. A copy of
the permission obtained must accompany the manuscript. Copies of
any and all published articles or other manuscripts in
preparation or submitted elsewhere that are related to the
manuscript must also accompany the manuscript. The material
should be sent to any of the two addresses given above.
|
Types of Manuscripts |
|
Original articles:
These include randomized controlled trials, intervention
studies, studies of screening and diagnostic test, outcome
studies, cost effectiveness analyses, case-control series, and
surveys with high response rate. The text of original articles
amounting to up to 3000 words (excluding Abstract, references
and Tables) should be divided into sections with the headings
Abstract, Key-words, Introduction, Material and Methods,
Results, Discussion, References, Tables and Figure legends.
Introduction: State the purpose and summarize the rationale
for the study or observation.
Materials and Methods: It should include and describe the
following aspects:
Ethics:
When reporting studies on human beings, indicate whether the
procedures followed were in accordance with the ethical
standards of the responsible committee on human experimentation
(institutional or regional) and with the Helsinki Declaration of
1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html).
For prospective studies involving human participants, authors
are expected to mention about approval of (regional/ national/
institutional or independent Ethics Committee or Review Board,
obtaining informed consent from adult research participants and
obtaining assent for children aged over 7 years participating in
the trial. The age beyond which assent would be required could
vary as per regional and/ or national guidelines. Ensure
confidentiality of subjects by desisting from mentioning
participants’ names, initials or hospital numbers, especially in
illustrative material. When reporting experiments on animals,
indicate whether the institution’s or a national research
council’s guide for, or any national law on the care and use of
laboratory animals was followed.
Evidence for approval by a local Ethics Committee (for both
human as well as animal studies) must be supplied by the authors
on demand. Animal experimental procedures should be as humane as
possible and the details of anesthetics and analgesics used
should be clearly stated. The ethical standards of experiments
must be in accordance with the guidelines provided by the CPCSEA
and World Medical Association Declaration of Helsinki on Ethical
Principles for Medical Research Involving Humans for studies
involving experimental animals and human beings, respectively).
The journal will not consider any paper which is ethically
unacceptable. A statement on ethics committee permission and
ethical practices must be included in all research articles
under the ‘Materials and Methods’ section.
Study design:
Selection and Description of Participants: Describe
your selection of the observational or experimental participants
(patients or laboratory animals, including controls) clearly,
including eligibility and exclusion criteria and a description
of the source population. Technical information: Identify the
methods, apparatus (give the manufacturer's name and address in
parentheses), and procedures in sufficient detail to allow other
workers to reproduce the results. Give references to established
methods, including statistical methods (see below); provide
references and brief descriptions for methods that have been
published but are not well known; describe new or substantially
modified methods, give reasons for using them, and evaluate
their limitations. Identify precisely all drugs and chemicals
used, including generic name(s), dose(s), and route(s) of
administration.
Reports of randomized clinical trials should present
information on all major study elements, including the protocol,
assignment of interventions (methods of randomization,
concealment of allocation to treatment groups), and the method
of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).
Reporting Guidelines for Specific Study Designs
Statistics:
Whenever possible quantify findings and present them with
appropriate indicators of measurement error or uncertainty (such
as confidence intervals). Authors should report losses to
observation (such as, dropouts from a clinical trial). When data
are summarized in the Results section, specify the statistical
methods used to analyze them. Avoid non-technical uses of
technical terms in statistics, such as 'random' (which implies a
randomizing device), 'normal', 'significant', 'correlations',
and 'sample'. Define statistical terms, abbreviations, and most
symbols. Specify the computer software used. Use upper italics
(P 0.048). For all P values include the exact value and not less
than 0.05 or 0.001. Mean differences in continuous variables,
proportions in categorical variables and relative risks
including odds ratios and hazard ratios should be accompanied by
their confidence intervals.
Results:
Present your results in a logical sequence in the text,
tables, and illustrations, giving the main or most important
findings first. Do not repeat in the text all the data in the
tables or illustrations; emphasize or summarize only important
observations. Extra- or supplementary materials and technical
detail can be placed in an appendix where it will be accessible
but will not interrupt the flow of the text; alternatively, it
can be published only in the electronic version of the journal.
When data are summarized in the Results section, give numeric
results not only as derivatives (for example, percentages) but
also as the absolute numbers from which the derivatives were
calculated, and specify the statistical methods used to analyze
them. Restrict tables and figures to those needed to explain the
argument of the paper and to assess its support. Use graphs as
an alternative to tables with many entries; do not duplicate
data in graphs and tables. Where scientifically appropriate,
analyses of the data by variables such as age and sex should be
included.
Discussion:
Include summary of key findings (primary outcome measures,
secondary outcome measures, results as they relate to a prior
hypothesis); Strengths and limitations of the study (study
question, study design, data collection, analysis and
interpretation); Interpretation and implications in the context
of the totality of evidence (is there a systematic review to
refer to, if not, could one be reasonably done here and now?,
what this study adds to the available evidence, effects on
patient care and health policy, possible mechanisms);
Controversies raised by this study; and Future research
directions (for this particular research collaboration,
underlying mechanisms, clinical research).
Do not repeat in detail data or other material given in the
Introduction or the Results section. In particular, contributors
should avoid making statements on economic benefits and costs
unless their manuscript includes economic data and analyses.
Avoid claiming priority and alluding to work that has not been
completed. New hypotheses may be stated if needed, however they
should be clearly labeled as such. About 30 references can be
included. These articles generally should not have more than six
authors.
Review Articles:
It is expected that these articles would be written by
individuals who have done substantial work on the subject or are
considered experts in the field. A short summary of the work
done by the contributor(s) in the field of review should
accompany the manuscript.
The prescribed word count is up to 3000 words excluding
tables, references and abstract. The manuscript may have about
90 references. The manuscript should have an unstructured
Abstract (250 words) representing an accurate summary of the
article. The section titles would depend upon the topic
reviewed. Authors submitting review article should include a
section describing the methods used for locating, selecting,
extracting, and synthesizing data. These methods should also be
summarized in the abstract.
The journal expects the contributors to give post-publication
updates on the subject of review. The update should be brief,
covering the advances in the field after the publication of the
article and should be sent as a letter to editor, as and when
major development occurs in the field.
Case reports/Brief communication:
New, interesting and rare cases can be reported. They should
be unique, describing a great diagnostic or therapeutic
challenge and providing a learning point for the readers. Cases
with clinical significance or implications will be given
priority. These communications could be of up to 1000 words
(excluding Abstract and references) and should have the
following headings: Abstract (unstructured), Key-words,
Introduction, Case report, Discussion, Reference, Tables and
Legends in that order.
The manuscript could be of up to 1000 words (excluding
references and abstract) and could be supported with up to 10
references. Case Reports could be authored by up to four
authors.
Letter to the Editor:
These should be short and decisive observations. They should
preferably be related to articles previously published in the
Journal or views expressed in the journal. They should not be
preliminary observations that need a later paper for validation.
The letter could have up to 500 words and 5 references. It could
be generally authored by not more than four authors.
Other:Editorial, Guest Editorial, and Commentaries, Archives of
Ayurveda/ Medicinal plants & Formulations, data on
centers/academic institutes conducting research in Traditional
Medicine, Research methods / Protocols for Ayurveda, Statistics
for Ayurveda, News and Views/ Literature snippets are solicited
by the editorial board.
References
References should be numbered consecutively in the order in
which they are first mentioned in the text (not in alphabetic
order). Identify references in text, tables, and legends by
Arabic numerals in superscript with square bracket after the
punctuation marks. References cited only in tables or figure
legends should be numbered in accordance with the sequence
established by the first identification in the text of the
particular table or figure. Use the style of the examples below,
which are based on the formats used by the NLM in Index Medicus.
The titles of journals should be abbreviated according to the
style used in Index Medicus. Use complete name of the journal
for non-indexed journals. Avoid using abstracts as references.
Information from manuscripts submitted but not accepted should
be cited in the text as "unpublished observations" with written
permission from the source. Avoid citing a "personal
communication" unless it provides essential information not
available from a public source, in which case the name of the
person and date of communication should be cited in parentheses
in the text.
The commonly cited types of references are shown here, for
other types of references such as newspaper items please refer
to ICMJE Guidelines (
http://www.icmje.org or
http://www.nlm.nih.gov/bsd/uniform_requirements.html ).
Articles in Journals
- Standard journal article (for up to six authors): Shukla
N, Husain N, Agarwal GG, Husain M. Utility of cysticercus
fasciolaris antigen in Dot ELISA for the diagnosis of
neurocysticercosis. Indian J Med Sci 2008;62:222-7.
- Standard journal article (for more than six authors):
List the first six contributors followed by et al.
Nozari Y, Hashemlu A, Hatmi ZN, Sheikhvatan M, Iravani A,
Bazdar A, et al. Outcome of coronary artery bypass grafting
in patients without major risk factors and patients with at
least one major risk factor for coronary artery disease.
Indian J Med Sci 2007;61:547-54
- Volume with supplement: Shen HM, Zhang QF. Risk
assessment of nickel carcinogenicity and occupational lung
cancer. Environ Health Perspect 1994; 102 Suppl 1:275-82.
- Issue with supplement: Payne DK, Sullivan MD, Massie MJ.
Women's psychological reactions to breast cancer. Semin
Oncol 1996; 23(1, Suppl 2):89-97.
Books and Other Monographs
- Personal author(s): Ringsven MK, Bond D. Gerontology and
leadership skills for nurses. 2nd ed. Albany (NY): Delmar
Publishers; 1996.
- Editor(s), compiler(s) as author: Norman IJ, Redfern SJ,
editors. Mental health care for elderly people. New York:
Churchill Livingstone; 1996.
- Chapter in a book: Phillips SJ, Whisnant JP.
Hypertension and stroke. In: Laragh JH, Brenner BM, editors.
Hypertension: pathophysiology, diagnosis, and management.
2nd ed. New York: Raven Press; 1995. pp. 465-78.
Electronic Sources as reference
Journal article on the Internet
Abood S. Quality improvement initiative in nursing homes:
the ANA acts in an advisory role. Am J Nurs [serial on the
Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.].
Available from:
http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
Monograph on the Internet
Foley KM, Gelband H, editors. Improving palliative care
for cancer [monograph on the Internet]. Washington: National
Academy Press; 2001 [cited 2002 Jul 9]. Available from:
http://www.nap.edu/books/0309074029/html/.
Homepage/Web site
Cancer-Pain.org [homepage on the Internet]. New York:
Association of Cancer Online Resources, Inc.; c2000-01
[updated 2002 May 16; cited 2002 Jul 9]. Available from:
http://www.cancer-pain.org/.
Part of a homepage/Web site
American Medical Association [homepage on the Internet].
Chicago: The Association; c1995-2002 [updated 2001 Aug 23;
cited 2002 Aug 12]. AMA Office of Group Practice Liaison;
[about 2 screens]. Available from:
http://www.ama-assn.org/ama/pub/category/1736.html
Download a PowerPoint presentation on common reference styles and using the reference checking facility on the manuscript submission site.
Tables
- Tables should be self-explanatory and should not
duplicate textual material.
- Tables with more than 10 columns and 25 rows are not
acceptable.
- Number tables, in Arabic numerals, consecutively in the
order of their first citation in the text and supply a brief
title for each.
- Place explanatory matter in footnotes, not in the
heading.
- Explain in footnotes all non-standard abbreviations that
are used in each table.
- Obtain permission for all fully borrowed, adapted, and
modified tables and provide a credit line in the footnote.
- For footnotes use the following symbols, in this
sequence: *, †, ‡, §, ||,¶ , **, ††, ‡‡
- Tables with their legends should be provided at the end
of the text after the references. The tables along with
their number should be cited at the relevant place in the
text
Illustrations (Figures)
- Upload the images in JPEG format. The file size should
be within 1024 kb in size while uploading.
- Figures should be numbered consecutively according to
the order in which they have been first cited in the text.
- Labels, numbers, and symbols should be clear and of
uniform size. The lettering for figures should be large
enough to be legible after reduction to fit the width of a
printed column.
- Symbols, arrows, or letters used in photomicrographs
should contrast with the background and should be marked
neatly with transfer type or by tissue overlay and not by
pen.
- Titles and detailed explanations belong in the legends
for illustrations not on the illustrations themselves.
- When graphs, scatter-grams or histograms are submitted
the numerical data on which they are based should also be
supplied.
- The photographs and figures should be trimmed to remove
all the unwanted areas.
- If photographs of individuals are used, their pictures
must be accompanied by written permission to use the
photograph.
- If a figure has been published elsewhere, acknowledge
the original source and submit written permission from the
copyright holder to reproduce the material. A credit line
should appear in the legend for such figures.
- Legends for illustrations: Type or print out legends
(maximum 40 words, excluding the credit line) for
illustrations using double spacing, with Arabic numerals
corresponding to the illustrations. When symbols, arrows,
numbers, or letters are used to identify parts of the
illustrations, identify and explain each one in the legend.
Explain the internal scale (magnification) and identify the
method of staining in photomicrographs.
- Final figures for print production: Send sharp, glossy,
un-mounted, color photographic prints, with height of 4
inches and width of 6 inches at the time of submitting the
revised manuscript. Print outs of digital photographs are
not acceptable. If digital images are the only source of
images, ensure that the image has minimum resolution of 300
dpi or 1800 x 1600 pixels in TIFF format. Send the images on
a CD. Each figure should have a label pasted (avoid use of
liquid gum for pasting) on its back indicating the number of
the figure, the running title, top of the figure and the
legends of the figure. Do not write the contributor/s'
name/s. Do not write on the back of figures, scratch, or
mark them by using paper clips.
- The Journal reserves the right to crop, rotate, reduce,
or enlarge the photographs to an acceptable size.
|
Protection of Patients' Rights to Privacy |
|
Identifying information should not be published in written
descriptions, photographs, sonograms, CT scans, etc., and
pedigrees unless the information is essential for scientific
purposes and the patient (or parent or guardian, wherever
applicable) gives written informed consent for publication.
Authors should remove patients' names from figures unless they
have obtained written informed consent from the patients. When
informed consent has been obtained, it should be indicated in
the article and copy of the consent should be attached with the
covering letter.
|
Sending a revised manuscript |
|
The revised version of the manuscript should be submitted
online in a manner similar to that used for submission of the
manuscript for the first time. However, there is no need to
submit the “First Page” or “Covering Letter” file while
submitting a revised version. When submitting a revised
manuscript, contributors are requested to include, the
‘referees’ remarks along with point to point clarification at
the beginning in the revised file itself. In addition, they are
expected to mark the changes as underlined or colored text in
the article.
|
Reprints and proofs |
|
Journal provides no free printed reprints. Authors can
purchase reprints, payment for which should be done at the time
of submitting the proofs. Proofs will be sent to the
corresponding authors by email approximately 2 weeks before the
publication date. The issues are published in last week of the
previous month.
|
Manuscript submission, processing and publication charges |
|
Journal does not charge the authors or authors’ institutions
for the submission, processing and/or publications of
manuscripts.
|
Copyrights |
|
The entire contents of the International Journal of Ayurveda
Researchare protected under Indian and international copyrights.
The Journal, however, grants to all users a free, irrevocable,
worldwide, perpetual right of access to, and a license to copy,
use, distribute, perform and display the work publicly and to
make and distribute derivative works in any digital medium for
any reasonable non-commercial purpose, subject to proper
attribution of authorship and ownership of the rights. The
journal also grants the right to make small numbers of printed
copies for their personal non-commercial use under Creative
Commons Attribution-Noncommercial-Share Alike 3.0 Unported
License.
|
Checklist |
|
Covering letter
- Signed by all contributors
- Previous publication / presentations mentioned
- Source of funding mentioned
- Conflicts of interest disclosed
Authors
- Last name and given name provided along with Middle name
initials (where applicable)
- Author for correspondence, with e-mail address provided
- Number of contributors restricted as per the
instructions
- Identity not revealed in paper except title page (e.g.
name of the institute in Methods, citing previous study as
'our study', names on figure labels, name of institute in
photographs, etc.)
Presentation and format
- Double spacing
- Margins 2.5 cm from all four sides
- Page numbers included at bottom
- Title page contains all the desired information
- Running title provided (not more than 50 characters)
- Abstract page contains the full title of the manuscript
- Abstract provided (structured abstract of 250 words for
original articles, unstructured abstracts of about 150 words
for all other manuscripts excluding letters to the Editor)
- Key words provided (three or more)
- Introduction of 75-100 words
- Headings in title case (not ALL CAPITALS)
- The references cited in the text should be after
punctuation marks, in superscript with square bracket.
- References according to the journal's instructions,
punctuation marks checked
- Send the article file without ‘Track Changes’
Language and grammar
- Uniformly UK English
- Write the full term for each abbreviation at its first
use in the title, abstract, keywords and text separately
unless it is a standard unit of measure. Numerals from 1 to
10 spelt out
- Numerals at the beginning of the sentence spelt out
- Check the manuscript for spelling, grammar and
punctuation errors
- If a brand name is cited, supply the manufacturer's name
and address (city and state/country).
- Species names should be in italics
Tables and figures
- No repetition of data in tables and graphs and in text
- Actual numbers from which graphs drawn, provided
- Figures necessary and of good quality (colour)
- Table and figure numbers in Arabic letters (not Roman)
- Labels pasted on back of the photographs (no names
written)
- Figure legends provided (not more than 40 words)
- Patients' privacy maintained (if not permission taken)
- Credit note for borrowed figures/tables provided
- Write the full term for each abbreviation used in the
table as a footnote
|
|
|
|
